Page last updated: 2024-08-26

mci 9038 and Chronic Liver Failure

mci 9038 has been researched along with Chronic Liver Failure in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Rondina, MT; Varedi, A; Walker, A; Yarbrough, PM	1

Other Studies

1 other study(ies) available for mci 9038 and Chronic Liver Failure

Article	Year
Argatroban dose reductions for suspected heparin-induced thrombocytopenia complicated by child-pugh class C liver disease. The Annals of pharmacotherapy, 2012, Volume: 46, Issue:11 Topics: Anticoagulants; Antithrombins; Arginine; End Stage Liver Disease; Heparin; Humans; Kidney Failure, Chronic; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Thrombocytopenia	2012

Article

Year

Argatroban dose reductions for suspected heparin-induced thrombocytopenia complicated by child-pugh class C liver disease.

The Annals of pharmacotherapy, 2012, Volume: 46, Issue:11

Topics: Anticoagulants; Antithrombins; Arginine; End Stage Liver Disease; Heparin; Humans; Kidney Failure, Chronic; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Thrombocytopenia

2012